Abstract:Vaccines comprising innovative adjuvants are rapidly reaching advanced translational stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID-19 worldwide, offering new strategies to effectively combat diseases threatening human health. Adjuvants are vital ingredients in vaccines, which can augment the degree, extensiveness, and longevity of antigen specific immune response. The advances in the modulation of physicochemical properties of nanoplatforms elevate the capability of adjuvants in initiating the innate immune system and adaptive immunity, offering immense potential for developing vaccines against hard-to-target infectious diseases and cancer. In this review, we provide an essential introduction of the basic principles of prophylactic and therapeutic vaccination, key roles of adjuvants in augmenting and shaping immunity to achieve desired outcomes and effectiveness, and the physiochemical properties and action mechanisms of clinically approved adjuvants for humans. We particularly focus on the preclinical and clinical progress of highly immunogenic emerging nanotechnology adjuvants formulated in vaccines for cancer treatment or infectious disease prevention. We deliberate on how the immune system can sense and respond to the physicochemical cues ( e.g. , chirality, deformability, solubility, topology, and chemical structures) of nanotechnology adjuvants incorporated in the vaccines. Finally, we propose possible strategies to accelerate the clinical implementation of nanotechnology adjuvanted vaccines, such as in-depth elucidation of nano-immuno interactions, antigen identification and optimization by the deployment of high-dimensional multiomics analysis approaches, encouraging close collaborations among scientists from different scientific disciplines and aggressive exploration of novel nanotechnologies.

Effects on immunization of the physicochemical parameters of particles as vaccine carriers

Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery

Advanced Materials for the Delivery of Vaccines for Infectious Diseases

Engineering Optimal Vaccination Strategies: Effects of Physical Properties of the Delivery System on Functions

Applications of polymer-based nanoparticles in vaccine field

Polyethylenimine-based Micro/nanoparticles As Vaccine Adjuvants

In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

Design of nanomaterial based systems for novel vaccine development

Advanced Oral Vaccine Delivery Strategies for Improving the Immunity

Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity

Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines.

Applications of Nanomaterials As Vaccine Adjuvants

Advancedoral vaccine delivery strategies for improving the immunity.

Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

Ph-Responsive Vaccine Delivery Systems for Improving Cellular Immunity

Nanocarriers of antigen proteins for vaccine delivery

Construction and Immunological Evaluation of Immunostimulatory Nanocomposites with Vaccine Potential

Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines

Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity